My Video Playlist »
Empty Playlist
|
|
|
A look at the eight big questions facing the pharmaceutical sector in 2008, with CNBC's Mike Huckman.
A look at the eight big questions facing the pharmaceutical sector in 2008, with CNBC's Mike Huckman.
0
|
A look at the eight big questions facing the pharmaceutical sector in 2008, with CNBC's Mike Huckman. |
|
|
|
|
|
|
CNBC's Mike Huckman has the details on a deal between Glaxo and Isis, potentially worth more than $1.5B, with Stanley Crooke,...
CNBC's Mike Huckman has the details on a deal between Glaxo and Isis, potentially worth more than $1.5B, with Stanley Crooke, Isis Pharmaceuticals chairman/CEO. (CNBC)...
|
CNBC's Mike Huckman has the details on a deal between Glaxo and Isis, potentially worth more than $1.5B, with Stanley Crooke,... |
|
|
|
|
|
|
Merck says it has seven drugs in late-stage testing, and CNBC's Mike Huckman has the details.
Merck says it has seven drugs in late-stage testing, and CNBC's Mike Huckman has the details.
0
|
Merck says it has seven drugs in late-stage testing, and CNBC's Mike Huckman has the details. |
|
|
|
|
|
|
A closer look at drug stocks, with CNBC's Mike Huckman. (CNBC) CNBC - Health - Business - Mike Huckman - Substance Abuse
A closer look at drug stocks, with CNBC's Mike Huckman. (CNBC) CNBC - Health - Business - Mike Huckman - Substance Abuse
|
A closer look at drug stocks, with CNBC's Mike Huckman. (CNBC) CNBC - Health - Business - Mike Huckman - Substance Abuse |
|
|
|
|
|
|
Pharmaceutical giant, Merck, is doubling down, with CNBC's Mike Huckman.
Pharmaceutical giant, Merck, is doubling down, with CNBC's Mike Huckman.
0
|
Pharmaceutical giant, Merck, is doubling down, with CNBC's Mike Huckman. |
|
|
|
|
|
|
A look at AIDS in 2006 with Mike Huckman, featuring Dr. Lynn Marks, Senior Vice President Of Infectious Diseases, GlaxoSmithK...
A look at AIDS in 2006 with Mike Huckman, featuring Dr. Lynn Marks, Senior Vice President Of Infectious Diseases, GlaxoSmithKline
0
|
A look at AIDS in 2006 with Mike Huckman, featuring Dr. Lynn Marks, Senior Vice President Of Infectious Diseases, GlaxoSmithK... |
|
|
|
|
|
|
A look at some smaller names, with CNBC's Mike Huckman. (CNBC) CNBC - Mike Huckman - New York Stock Exchange - Health care - ...
A look at some smaller names, with CNBC's Mike Huckman. (CNBC) CNBC - Mike Huckman - New York Stock Exchange - Health care - Business
|
A look at some smaller names, with CNBC's Mike Huckman. (CNBC) CNBC - Mike Huckman - New York Stock Exchange - Health care - ... |
|
|
|
|
|
|
Merck's guidance for this year is 28% above original forecasts this year, reports CNBC's Mike Huckman
Merck's guidance for this year is 28% above original forecasts this year, reports CNBC's Mike Huckman
0
|
Merck's guidance for this year is 28% above original forecasts this year, reports CNBC's Mike Huckman |
|
|
|
|
|
|
CNBC's Mike Huckman gets his flu shot.
CNBC's Mike Huckman gets his flu shot.
0
|
CNBC's Mike Huckman gets his flu shot. |
|
|
|
|
|
|
Local police in Connecticut this afternoon are meeting with the FBI to talk about next steps in the investigation into one of...
Local police in Connecticut this afternoon are meeting with the FBI to talk about next steps in the investigation into one of the biggest ever prescription drug heists, with...
|
Local police in Connecticut this afternoon are meeting with the FBI to talk about next steps in the investigation into one of... |
|
|
|
|
|
